mHealth Screening to Prevent Strokes

Completed · Not applicable

Conditions studied: Atrial Fibrillation

In brief

The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previously undiagnosed atrial fibrillation, and provide clinical evidence of an outcomes benefit associated with this early detection.

Key facts

Study ID

NCT02506244

Run by

Scripps Translational Science Institute

People needed

6135

Starts

2015-11-01

Expected to finish

2020-12-31

Last updated by the study team

2022-12-08

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or females age > 75 or
• Male age > 55, or females age > 65, and
• Prior CVA, or
• Heart failure, or
• Diagnosis of both diabetes and hypertension, or
• Mitral valve disease, or
• Left ventricular hypertrophy, or
• COPD requiring home O2, or
• Sleep apnea, or
• History of pulmonary embolism, or
• History of myocardial infarction, or
• Diagnosis of obesity

You may not qualify if…

• Current or prior diagnosis of atrial fibrillation, atrial flutter or atrial tachycardia
• Receiving chronic anticoagulation therapy
• Hospice care
• End stage renal disease
• Diagnosis of moderate or greater dementia
• Implantable pacemaker and/or defibrillator
• History of skin allergies to adhesive patches
• Known metastatic cancer
• Aetna Compassionate Care Program (ACCP) participants - individuals with advanced illness and limited life expectancy

Where it is running

• Scripps Translational Science Institute — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.